SELLAS Life Sciences Group, Inc. Stock Issued During Period, Shares, Employee Stock Purchase Plans
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SELLAS Life Sciences Group, Inc. stock issued during period, shares, employee stock purchase plans for fiscal 2016 was 29.07K shares, a 93.84% decline from fiscal 2015.
- SELLAS Life Sciences Group, Inc. stock issued during period, shares, employee stock purchase plans for fiscal 2015 was 471.87K shares.
- SELLAS Life Sciences Group, Inc. stock issued during period, shares, employee stock purchase plans for fiscal 2013 was 243.51K shares, a 27.51% increase from fiscal 2012.
- SELLAS Life Sciences Group, Inc. stock issued during period, shares, employee stock purchase plans for fiscal 2012 was 190.98K shares.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans 3 month | Stock Issued During Period, Shares, Employee Stock Purchase Plans 12 month |
|---|---|---|
| 2016-12-31 | 29.07K shares 10-K · filed 2017-03-15 | |
| 2015-12-31 | 471.87K shares 10-K/A · filed 2016-04-15 | |
| 2014-12-31 | 358.14K shares 8-K · filed 2015-12-04 | |
| 2013-12-31 | 243.51K shares 10-K · filed 2014-03-17 | |
| 2012-12-31 | 190.98K shares 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |